Emerging Technologies Live
image from bobmadbob from Getty Images

RNA Vaccines

Background

RNA vaccines are a new type of vaccine that uses pieces of genetic code from a virus or disease to help the body build immunity to that virus or disease. RNA vaccines are different from traditional vaccines, which use dead or weakened viruses or pieces of bacteria to help the body build immunity.

Some of the emerging trends in RNA vaccines include the use of CRISPR/Cas9 technology to create more targeted and effective vaccines, the use of next-generation sequencing to identify new targets for vaccination, and the use of synthetic biology to create more potent and specific vaccines.

See live data on companies, R&D, markets, and news

In order to access the link, you need a Mergeflow account.

No Mergeflow account yet?

No credit card, no software to install. Trial ends automatically after 14 days.

Teams and individuals from across industries and tech sectors use Mergeflow

Curious to see how it works?

Watch our free video course:

Frequently asked questions about the trial

After you sign up, you’ll receive an email from us with an account activation link. Over the course of the trial, we’ll send you emails with tips and tricks. The trial ends automatically after 14 days. No further obligations on your part.

No. We do not ask for your credit card up front, so you will only be charged when you decide to buy a subscription.

No. Mergeflow is a SaaS software that runs in any modern web browser. And because it’s a subscription, you get constant product updates.

You can pay your Innovator or Analyst subscription via credit card (American Express, MasterCard, Visa) or SEPA Direct Debits. The larger team plans, API and enterprise solutions can be paid via invoicing and bank transfer.

 

Yes. We don’t serve ads, we never sell anything you give us, and we protect your privacy.